Defining the Syrian hamster as a highly susceptible preclinical model for SARS-CoV-2 infection

Mostrar otras versiones (1)

Following emergence in late 2019, SARS-CoV-2 rapidly became pandemic and is presently responsible for millions of infections and hundreds of thousands of deaths worldwide. There is currently no approved vaccine to halt the spread of SARS-CoV-2 and only very few treatment options are available to man...

Descripción completa

Detalles Bibliográficos
Autores principales: Rosenke, Kyle, Meade-White, Kimberly, Letko, Michael, Clancy, Chad, Hansen, Frederick, Liu, Yanan, Okumura, Atsushi, Tang-Huau, Tsing-Lee, Li, Rong, Saturday, Greg, Feldmann, Friederike, Scott, Dana, Wang, Zhongde, Munster, Vincent, Jarvis, Michael A., Feldmann, Heinz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7523093/
https://www.ncbi.nlm.nih.gov/pubmed/32995767
http://dx.doi.org/10.1101/2020.09.25.314070

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7523093/
https://www.ncbi.nlm.nih.gov/pubmed/32995767
http://dx.doi.org/10.1101/2020.09.25.314070

Ejemplares similares